P3.13-32 Drug Sensitivity of Lung Adenocarcinoma Towards Inducers of Epigenetic Modifications

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1873
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Identification of Regulatory SNPs Associated With Genetic Modifications in Lung Adenocarcinoma

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2015English

P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.13-19 Surgery for cIIIB Lung Adenocarcinoma After Response to Erlotinib, Survival and Management of Postoperative Oligoprogressions

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.13-27 Clinical Outcomes of Patients With Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Single-Molecule Analysis of Colocalized Epigenetic Modifications

Biophysical Journal
Biophysics
2016English

P3.13-08 Assessment of EGFR Gene Mutations in Cf-Dna in Monitoring of Response to EGFR TKIs in Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy

Seminars in Nephrology
Nephrology
2013English

Epigenetic Modifications in Human Thyroid Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2014English

Cellular Epigenetic Modifications of Neural Stem Cell Differentiation

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy